by Elena Iemma | Jun 10, 2021 | Featured, Thinking Out Loud -Blog
EpiVax has been busy helping our clients, and the research flywheel is spinning faster than ever. We needed more talented folks to pitch in! So far we’ve brought on six wonderful team members in 2021, with more to come soon! Learn more about our new folks below,...
by Elena Iemma | May 17, 2021 | Featured, News
PROVIDENCE, RI, May 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation” in NPJ Vaccines. This research identifies...
by Elena Iemma | May 13, 2021 | Featured, News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
by Elena Iemma | Apr 21, 2021 | Featured, Thinking Out Loud -Blog
Tregitopes: What Did Nature Intend? Hey everybody, it’s a good idea to pay attention to the forces of Nature, right? When we discovered that IgG (as in monoclonals) contained Treg epitopes (and named them “Tregitopes”) in 2008, we knew that this discovery was a...
by Elena Iemma | Feb 25, 2021 | Featured, Thinking Out Loud -Blog
When EpiVax CEO/CSO Annie De Groot began her decades-long focus on HIV vaccine research in the early 90’s, she couldn’t have predicted the implications for the COVID-19 pandemic…. Or perhaps she did! Interviewed by Michael Dumiak for August 2020 issue of IAVI, Annie...